The Federally-funded Texas A&M/GlaxoSmithKline Partnership in College Station has been enhanced by up to $200 million for medicine development contra pandemics, antibiotic resistance, and bioterrorism.
http://bionews-tx.com/news/2013/05/23/hhs-awards-additional-200m-to-texas-am-glaxosmithkline-antibiotic-development/
No comments:
Post a Comment